Respiratory Panel Kit

3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept

India

3B BlackBio Dx Group is one of India's leading companies in PCR-based molecular diagnostics, incorporated in November 2010. As an ISO 13485:2016 certified and GMP compliant biotech R&D organization, the Group is engaged in the design, development, manufacturing, and commercialization of PCR-based Molecular Diagnostic Kits, PCR Enzymes, and PCR Reagents, marketed under its flagship brand TRUPCR® to renowned diagnostic labs across India and beyond. With a highly trained R&D team experienced across multiple disease parameters, the Group has the capability to develop new diagnostic solutions in a remarkably short span of time. The Group's global footprint is strengthened through its subsidiaries - TRUPCR Europe and Coris BioConcept. TRUPCR Europe manufactures and supplies high-quality qPCR and NGS molecular diagnostic products worldwide, backed by a team with over 30 years of experience in the molecular diagnostics and healthcare sectors. Coris BioConcept, based in Belgium and a recognized expert in rapid in vitro diagnostics since 1996, develops and markets IVD kits for respiratory, gastroenteric, and blood-borne pathogens, as well as pioneering assays for Anti-Microbial Resistance detection, including the innovative RESIST range and BL-RED technology. Both companies are CE marked and ISO 13485 certified, with Coris BioConcept's products distributed across more than 60 countries worldwide. 3B BlackBio Dx Group combines deep R&D expertise, cutting-edge technology, and decades of clinical experience to deliver innovative and reliable diagnostic solutions across the globe. Committed to enhancing laboratory efficiency and improving patient care, the Group offers comprehensive technical support and training, making it a trusted partner for diagnostic laboratories and healthcare institutions worldwide.